| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |